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Introduction: During the coronavirus disease 2019 (COVID-19) pandemic, emergency providers 
are not only seeing an increasing number of patients with COVID-19 infections, but also associated 
complications and sequelae of this viral illness. 
Case Report: We present the case of a 28-year-old female patient who presented after a confirmed 
COVID-19 infection with lower back pain, bilateral symmetric upper and lower extremity numbness, 
and urinary retention. The patient was diagnosed with acute transverse myelitis. She required 
intravenous corticosteroids and plasma exchange with significant improvement in symptoms and 
minimal residual effects.
Conclusion: This case illustrates the importance of prompt recognition and treatment of sequelae of 
COVID-19 infections. [Clin Pract Cases Emerg Med. 2020;4(3):X–X.]   
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INTRODUCTION 
The novel coronavirus pandemic has resulted in significant 
mortality and morbidity, with almost two million cases 
and over 100,000 deaths worldwide as of mid-April 2020.1 
Coronavirus disease 2019 (COVID-19), the illness caused by 
the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), presents similarly to other viral respiratory illnesses 
with common symptoms including fever, cough, fatigue, 
myalgias, and diarrhea. Some patients develop respiratory 
distress requiring supplemental oxygen or ventilator support, 
while others have mild cases without complications. Given the 
recent and rapidly progressing nature of the pandemic, exact 
statistics are unknown, although estimates suggest that 80% of 
patients experience mild illness.2 Less appreciated still are the 
complications, sequelae, and long-term effects of COVID-19. 
We present a case of acute transverse myelitis following 
COVID-19 infection in a young and otherwise healthy patient. 
CASE REPORT 
A 28-year-old female with a history of hypothyroidism on 
levothyroxine developed symptoms of productive cough, low-
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grade temperatures, low back pain, myalgias, and rhinorrhea 
during the novel coronavirus pandemic. She tested positive for 
COVID-19 via an at-home swab ordered by her primary doctor. 
Her upper respiratory symptoms resolved over the next week, 
but her lumbosacral back pain persisted and worsened, although 
without radiation. In addition, she developed paresthesias in her 
lower extremities, which progressed to total loss of sensation 
and with ascension of symptoms up to her mid-chest below the 
nipple line and bilateral upper extremities, as well as numbness 
to the tip of her tongue. She also reported approximately 48 hours 
of urinary retention as well as nausea and vomiting. She did not 
have any headaches, dysarthria or dysphagia, vision changes, 
or dyspnea. She was admitted to a large, academic, tertiary care 
center in Denmark. 
The patient’s neurologic exam was notable for 
symmetrically decreased sensation below the fifth thoracic 
vertebra level but preserved two-point discrimination and 
lower-extremity motor strength. She experienced decreased 
proprioception and four out of five strength in bilateral upper 
extremities with intact reflexes throughout. Lhermitte’s sign 
(electric shock-like sensation down the back triggered by 
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What do we already know about this clinical 
entity? 
Transverse myelitis is a rare neurological 
condition causing inflammation of the 
spinal cord and is believed to develop via 
autoimmune mechanisms.
What makes this presentation of disease 
reportable? 
Transverse myelitis is a known sequelae of 
viral illnesses such as influenza, but has 
heretofore not been associated with novel 
coronavirus infections.
What is the major learning point? 
Patients can develop serious complications with 
lasting neurological effects even after initial 
recovery from novel coronavirus infection.
How might this improve emergency 
medicine practice? 
Emergency providers can prevent significant 
morbidity by recognizing post-infectious 
complications of novel coronavirus, 
including transverse myelitis.
bending the head forward) was positive and she had a wide-based 
gait. She retained 1.4 liters (L) of urine in her bladder, which was 
relieved after Foley catheter insertion. Lumbar puncture showed 
125/per microliter (/µl) mononuclear cells (laboratory reference 
range 0-5/µl); 0.6 grams per liter (g/L) protein (laboratory 
reference range 0.15 to 0.6 g/L)); normal glucose (laboratory 
reference range 45-80 milligram per deciliter); negative 
antibodies; and gram stain and culture negative for infection. 
Magnetic resonance imaging (MRI) with and without contrast 
of the cervical, thoracic, and lumbar spine showed widespread 
elongated signal changes throughout the spinal cord to the conus 
medullaris and involving the medulla, with no disc pathology 
or spinal canal narrowing. These findings were consistent 
with longitudinally extensive acute transverse myelitis (given 
involvement of more than three spinal cord segments), thought 
to be reactive in the setting of recent COVID-19 infection. The 
patient was started on prednisolone and received two plasma 
exchange treatments with rapid improvement of symptoms. After 
eight days in the hospital, she was discharged on a steroid taper 
with improved symptoms including normal urinary function. Her 
residual symptoms included decreased sensation in the lower 
extremities up to the mid-thighs bilaterally. 
DISCUSSION 
Transverse myelitis is a rare, acquired neurologic condition 
characterized by focal inflammation and injury of the spinal 
cord. There is a wide array of potential etiologies. Transverse 
myelitis is a recognized complication of viral or bacterial 
infections, although it can also be the first sign of neurologic 
conditions such as multiple sclerosis or neuromyelitis optica 
or associated with systemic autoimmune diseases such as 
lupus or sarcoidosis.3 Despite extensive workup, as many 
as 60% of cases may remain idiopathic, meaning the exact 
pathophysiology of the disease is unknown and varies based 
on etiology.4 When related to an infectious cause, it is often 
attributed to an autoimmune-mediated response as opposed to 
direct invasion and injury of the spinal cord.5 In these cases, 
intravenous corticosteroids are started immediately to suppress 
the inflammatory response and plasma exchange is a potential 
treatment option to remove auto-antibodies.6
This patient presented with the hallmark symptoms of 
transverse myelitis including bilateral symmetric sensory 
changes and extremity weakness, lower back pain, and 
bladder dysfunction, and had classic contrast-enhancing 
lesions on MRI. Given the onset of these findings in the 
setting of a confirmed COVID-19 case, as well as her 
marked improvement with steroids and plasma exchange, 
it is likely that this was an autoimmune-mediated response 
to the novel coronavirus. Furthermore, she had no visual 
symptoms such as eye pain or vision loss that are classically 
seen in multiple sclerosis or neuromyelitis optica, nor the 
immunoglobulin G auto-antibodies or oligoclonal bands that 
are the immunological hallmarks of these diseases.7 Likewise 
her anti-nuclear antibody test, very sensitive for autoimmune 
disorders including lupus, was negative, nor did she have any 
other system involvement such as skin rash or nodules, cardiac 
arrhythmias, or arthritis, which are also seen with conditions 
like lupus or sarcoidosis.8
CONCLUSION
As the number of COVID-19 infections continues 
to rise, more patients are presenting to the emergency 
department with novel coronavirus-related symptoms and 
associated complications. Healthcare workers, especially 
emergency providers on the frontlines, treat these affected 
patients and bear witness to their different presentations and 
clinical courses. This case report emphasizes the importance 
of remaining cognizant of the atypical and less-prevalent 
sequelae of viral infections in patients with recent or 
concurrent COVID-19 infections, as prompt recognition and 
management are important to prevent significant morbidity. It 
also highlights that young and otherwise healthy patients who 
have seemingly recovered from COVID-19 infection can still 
develop serious complications. These are important takeaways 
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for emergency providers in the midst of providing care during 
this global pandemic. 
The authors attest that their institution requires neither Institutional 
Review Board approval, nor patient consent for publication of this 
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